Skip to main content

Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025.

Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

Contacts

Media Contact: Amy Hytowitz, 949-250-5070

Investor Contact: Mark Wilterding, 949-250-6826

Recent Quotes

View More
Symbol Price Change (%)
AMZN  216.79
+8.06 (3.86%)
AAPL  263.22
-0.53 (-0.20%)
AMD  202.25
+11.30 (5.92%)
BAC  50.20
+0.23 (0.45%)
GOOG  302.85
-0.71 (-0.23%)
META  668.96
+13.88 (2.12%)
MSFT  409.33
+5.40 (1.34%)
NVDA  183.79
+3.74 (2.08%)
ORCL  153.37
+4.36 (2.92%)
TSLA  405.03
+12.60 (3.21%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.